Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Using asymmetrical toric intraocular lenses to improve vision for people with irregular corneas

Official title: VITAL - "Visual Improvement With Toric Asymmetrical Lenses": Enhancing Vision in Irregular Corneas

Run by Johannes Kepler University of Linz · NCT07294716 · Data updated 2026-11-12

This will test a custom asymmetrical toric intraocular lens during cataract surgery to reduce irregular astigmatism and improve vision in adults with irregular corneas.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment15 (estimated)
SponsorJohannes Kepler University of Linz
Academic / other
Locations1 site (Linz)
StatusRecruiting
StartedJanuary 20, 2026
Main results expectedJanuary 2027
Study endsJune 2027
Registry record updatedJanuary 26, 2026
Trial IDNCT07294716 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 21 or older scheduled for cataract surgery with CASIA2-measured total astigmatism ≥1.75 D and ≥0.75 D of asymmetry or higher-order irregularity within the 6 mm corneal zone.

Probably not a fit

Patients with relevant central corneal scars, pseudoexfoliation (PEX), prior ocular surgery or severe trauma, combined surgical procedures, an unstable capsular bag, expected postoperative BCVA below 0.3 Snellen, or who are pregnant are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Cataract surgery in eyes with irregular corneas is challenging because variable keratometry and corneal tomography make IOL power and astigmatism calculations unpredictable. This exploratory interventional protocol implants a custom asymmetrical toric intraocular lens (AMILens Individual) to target total astigmatism, including irregular components identified on CASIA2 corneal maps. Eligible participants are adults with at least 1.75 D total astigmatism and at least 0.75 D of asymmetry or higher-order irregularity within the central 6 mm zone; key exclusions include central corneal scars, prior ocular surgery, pseudoexfoliation or any condition risking an unstable capsular bag. Outcomes will focus on refractive results, visual acuity, and postoperative stability at a single center in Linz, Austria.

Why it matters

Potential benefit: If successful, the lens could reduce irregular astigmatism at the time of cataract surgery and improve uncorrected vision and quality of life for affected patients.

How similar studies have gone: Conventional toric IOLs have shown benefit for regular astigmatism, but using asymmetrical toric lenses to correct irregular astigmatism is relatively novel with limited published data so far.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 21 years or older
* Scheduled cataract surgery
* At least 1.75 D of total astigmatism in the CASIA2 measurement
* At least 0.75 D of asymmetry or higher order irregularity within the 6mm zone of the real (total) index corneal refractive map of the CASIA2 measurements

Exclusion Criteria:

* Relevant central corneal scars
* PEX, previous ocular surgery, severe trauma or any pathology that could lead to an unstable capsular bag
* Combined surgery (cataract plus glaucoma/vitreoretinal/corneal surgery)
* Postoperative best corrected distance visual acuity below 0.3 Snellen decimal
* Pregnancy

Where it's running

  • Kepler University Clinic, Department for Ophthalmology and Optometry
    Linz, Austria
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.